 <h1>Lioresal Intrathecal Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>baclofen</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about baclofen. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Lioresal Intrathecal.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to baclofen: oral powder for suspension, oral solution, oral tablet</i></p><p>Other dosage forms:</p><ul><li>intrathecal solution</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, baclofen (the active ingredient contained in Lioresal Intrathecal) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking baclofen:</p><p>
<i>Less common or rare</i>
</p><ul>
<li>Bloody or dark urine</li>
<li>chest pain</li>
<li>fainting</li>
<li>mental depression or other mood changes</li>
<li>ringing or buzzing in the ears</li>
<li>seeing or hearing things that are not there</li>
<li>skin rash or itching</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking baclofen:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Blurred vision</li>
<li>convulsions</li>
<li>difficult or troubled breathing</li>
<li>dizziness</li>
<li>drowsiness</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>lightheadedness</li>
<li>loss of strength or energy</li>
<li>muscle pain or weakness</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>sleepiness or unusual drowsiness</li>
<li>unusual weak feeling</li>
<li>unusually slow or troubled breathing</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of baclofen may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Confusion</li>
<li>constipation</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>headache</li>
<li>increased need to urinate</li>
<li>nausea</li>
<li>passing urine more often</li>
<li>sweating</li>
<li>trouble sleeping</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common or rare</i>
</p><ul>
<li>Abdominal or stomach pain or discomfort</li>
<li>clumsiness, unsteadiness, trembling, or other problems with muscle control </li>
<li>diarrhea</li>
<li>false sense of well-being</li>
<li>loss of appetite</li>
<li>muscle or joint pain</li>
<li>numbness or tingling in the hands or feet</li>
<li>pounding heartbeat</li>
<li>slurred speech or other speech problems </li>
<li>stuffy nose</li>
<li>swelling of the ankles</li>
<li>unexplained muscle stiffness</li>
<li>unusual excitement</li>
<li>weight gain</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to baclofen: compounding powder, intrathecal solution, oral liquid, oral suspension, oral tablet</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Cardiac output decreased, hypotension, hypertension, diminished cardiovascular functions, peripheral edema</p>
<p><b>Rare</b> (less than 0.1%): Arrhythmias, palpitations, chest pain</p>
<p><b>Frequency not reported</b>: Bradycardia, orthostatic hypotension<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, hyperhidrosis, urticaria/pruritus, facial edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Alopecia, diaphoresis</p>
<p><b>Frequency not reported</b>: Rash, sweating, contact dermatitis, skin ulcer<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Ovarian cysts are palpable in 4% of women treated with for up to one year<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (especially at start of therapy) (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Dry mouth, GI disorder/disturbance, constipation, diarrhea, retching, vomiting, increased salivation</p>
<p><b>Uncommon</b> (0.1% to 1%): Dysphagia, dehydration, ileus, decreased taste sensation</p>
<p><b>Rare</b> (less than 0.1%): Colicky abdominal pain, anorexia </p>
<p><b>Frequency not reported</b>: GI hemorrhage<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary retention (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Urinary incontinence, urination impaired, sexual dysfunction, urinary frequency, enuresis, dysuria</p>
<p><b>Rare</b> (less than 0.1%): Erectile dysfunction </p>
<p><b>Frequency not reported</b>: Dysuria, abnormal ejaculation, oliguria, vaginitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Leukocytosis, petechial rash<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Disorders of hepatic function (e.g., increased AST)<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Pneumonia</p>
<p><b>Uncommon</b> (0.1% to 1%): Septicemia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p>
<p><b>Frequency not reported</b>: Blood glucose increased<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Hypotonia (up to 52%), lower extremity weakness (up to 15%), disturbances of gait and balance</p>
<p><b>Common</b> (1% to 10%): Muscular weakness, myalgia, upper extremity weakness, back pain, muscular hypertonia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Somnolence (up to 28%), drowsiness (up to 18%), headache (up to 16%), seizures (especially on discontinuation of therapy) (up to 15%), sedation, dizziness (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Fatigue, ataxia, tremor, lightheadedness, lassitude, exhaustion, numbness/itching/tingling, slurred speech, lethargy, hypertonia, paresthesia</p>
<p><b>Rare</b> (less than 0.1%): Dysarthria, dysgeusia, syncope, dyskinesia, coma, potentially life-threatening withdrawal symptoms (as a result of sudden interruption of drug delivery)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Tinnitus, pain, asthenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Accidental injury, weight loss</p>
<p><b>Very rare</b> (less than 0.01%): Hypothermia</p>
<p><b>Frequency not reported</b>: Drug withdrawal syndrome</p>
<p><b>Uncommon</b> (0.1% to 1%): Subdural hemorrhage, accidental injury, weight loss<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Nystagmus, visual impairment, accommodation disorder, blurred vision, double vision, amblyopia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Confusional state, hallucination, depression, insomnia, euphoric mood, nightmare, personality changes</p>
<p><b>Uncommon</b> (0.1% to 1%): Memory loss/impairment, suicidal ideation, attempted suicide</p>
<p><b>Rare</b> (less than 0.1%): Excitement<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Kidney calculus<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Respiratory depression, hypoventilation, dyspnea, bradypnea, feeling of pressure in the chest<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Lioresal (baclofen)." Medtronic Inc, Minneapolis, MN. </p><p id="ref_3">3. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_4">4. "Product Information. Lioresal Intrathecal (baclofen)." Medtronic Inc, Minneapolis, MN. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Lioresal Intrathecal (baclofen)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>2 Reviews</li>
<li>Drug class: skeletal muscle relaxants</li>
<li>FDA Alerts (4)</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Gablofen, Ozobax</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Lioresal</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Cerebral Spasticity</li>
<li>Chronic Spasticity</li>
<li>Spasticity</li>
<li>Spinal Spasticity</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to baclofen: compounding powder, intrathecal solution, oral liquid, oral suspension, oral tablet</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Cardiac output decreased, hypotension, hypertension, diminished cardiovascular functions, peripheral edema</p><p><b>Rare</b> (less than 0.1%): Arrhythmias, palpitations, chest pain</p><p><b>Frequency not reported</b>: Bradycardia, orthostatic hypotension<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, hyperhidrosis, urticaria/pruritus, facial edema</p><p><b>Uncommon</b> (0.1% to 1%): Alopecia, diaphoresis</p><p><b>Frequency not reported</b>: Rash, sweating, contact dermatitis, skin ulcer<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Ovarian cysts are palpable in 4% of women treated with for up to one year<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (especially at start of therapy) (up to 11%)</p><p><b>Common</b> (1% to 10%): Dry mouth, GI disorder/disturbance, constipation, diarrhea, retching, vomiting, increased salivation</p><p><b>Uncommon</b> (0.1% to 1%): Dysphagia, dehydration, ileus, decreased taste sensation</p><p><b>Rare</b> (less than 0.1%): Colicky abdominal pain, anorexia </p><p><b>Frequency not reported</b>: GI hemorrhage<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary retention (up to 12%)</p><p><b>Common</b> (1% to 10%): Urinary incontinence, urination impaired, sexual dysfunction, urinary frequency, enuresis, dysuria</p><p><b>Rare</b> (less than 0.1%): Erectile dysfunction </p><p><b>Frequency not reported</b>: Dysuria, abnormal ejaculation, oliguria, vaginitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Leukocytosis, petechial rash<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Disorders of hepatic function (e.g., increased AST)<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Pneumonia</p><p><b>Uncommon</b> (0.1% to 1%): Septicemia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p><p><b>Frequency not reported</b>: Blood glucose increased<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Hypotonia (up to 52%), lower extremity weakness (up to 15%), disturbances of gait and balance</p><p><b>Common</b> (1% to 10%): Muscular weakness, myalgia, upper extremity weakness, back pain, muscular hypertonia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Somnolence (up to 28%), drowsiness (up to 18%), headache (up to 16%), seizures (especially on discontinuation of therapy) (up to 15%), sedation, dizziness (up to 12%)</p><p><b>Common</b> (1% to 10%): Fatigue, ataxia, tremor, lightheadedness, lassitude, exhaustion, numbness/itching/tingling, slurred speech, lethargy, hypertonia, paresthesia</p><p><b>Rare</b> (less than 0.1%): Dysarthria, dysgeusia, syncope, dyskinesia, coma, potentially life-threatening withdrawal symptoms (as a result of sudden interruption of drug delivery)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Tinnitus, pain, asthenia</p><p><b>Uncommon</b> (0.1% to 1%): Accidental injury, weight loss</p><p><b>Very rare</b> (less than 0.01%): Hypothermia</p><p><b>Frequency not reported</b>: Drug withdrawal syndrome</p><p><b>Uncommon</b> (0.1% to 1%): Subdural hemorrhage, accidental injury, weight loss<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Nystagmus, visual impairment, accommodation disorder, blurred vision, double vision, amblyopia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Confusional state, hallucination, depression, insomnia, euphoric mood, nightmare, personality changes</p><p><b>Uncommon</b> (0.1% to 1%): Memory loss/impairment, suicidal ideation, attempted suicide</p><p><b>Rare</b> (less than 0.1%): Excitement<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Kidney calculus<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Respiratory depression, hypoventilation, dyspnea, bradypnea, feeling of pressure in the chest<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Lioresal (baclofen)." Medtronic Inc, Minneapolis, MN. </p><p id="ref_3">3. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_4">4. "Product Information. Lioresal Intrathecal (baclofen)." Medtronic Inc, Minneapolis, MN. </p><h2>More about Lioresal Intrathecal (baclofen)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>2 Reviews</li>
<li>Drug class: skeletal muscle relaxants</li>
<li>FDA Alerts (4)</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Lioresal</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Cerebral Spasticity</li>
<li>Chronic Spasticity</li>
<li>Spasticity</li>
<li>Spinal Spasticity</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>